Recombinant Ret Proto-Oncogene (RET)

CDHR16; CRet; PTC; CDHF12; HSCR1; MEN2A; MEN2B; MTC1; RET-ELE1; RET51; C-Ret; Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1; Cadherin-Related 16

  • Recombinant Ret Proto-Oncogene (RET) Packages (Simulation)
  • Recombinant Ret Proto-Oncogene (RET) Packages (Simulation)
  • RPB293Mu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Ret Proto-Oncogene (RET)

USAGE of the Recombinant Ret Proto-Oncogene (RET)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Ret Proto-Oncogene (RET)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Ret Proto-Oncogene (RET)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Mus musculus (Mouse) Applications (RESEARCH USE ONLY!)
RPB293Mu01 Recombinant Ret Proto-Oncogene (RET) Positive Control; Immunogen; SDS-PAGE; WB.
MAB293Mu21 Monoclonal Antibody to Ret Proto-Oncogene (RET) WB; IHC; ICC; IP.
GUESTBOOK